Imperial recognised for leadership around openness on animal research
Carbon Cell raises £1.2m to scale its low carbon foam material
Celebrating Imperial’s role in UK’s thriving innovation ecosystem
Follow the links below to find out more about each of our research areas:
Imperial has made substantial contributions to the identification of genetic risks for diabetes with ongoing research across several departments as well as the NIHR-supported Imperial Biomedical Research Research Centre, the School of Public Health, and the Department of Medicine.
Find out more
The MRC-NIHR Phenome Centre undertakes world-class metabolite analysis and is open to the UK research community.
Imperial’s Nutrition and Food Network is promoting food and nutrition as a primary means of preventing and managing nutrition-related illnesses including obesity, diabetes and cardiovascular disease.
Imperial has active programmes in the understanding of feeding and the control of body weight, including the development of new therapies based on “incretin” hormones released from the gut.
Focussing on the biology of the pancreatic islet beta cell, whose failure is central to all forms of diabetes, the Pancreatic Islet Biology Consortium develops new insights which can be leveraged towards innovative new therapies.
